Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in J Biol Chem

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    August 2021
  1. LIU H, Lu Z, Shi X, Liu L, et al
    HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
    J Biol Chem. 2021;297:100996.
    PubMed     Abstract available


    January 2021
  2. ZHENG S, Matthews AJ, Rahman N, Herrick-Reynolds K, et al
    The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination.
    J Biol Chem. 2021;296:100625.
    PubMed     Abstract available


  3. KOKSAL H, Dillard P, Juzeniene A, Kvalheim G, et al
    Combinatorial CAR design improves target restriction.
    J Biol Chem. 2021;296:100116.
    PubMed     Abstract available


  4. LOPUSNA K, Nowialis P, Opavska J, Abraham A, et al
    Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
    J Biol Chem. 2021;296:100285.
    PubMed     Abstract available


    November 2020
  5. RINK JS, Lin AY, McMahon KM, Calvert AE, et al
    Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis.
    J Biol Chem. 2020;296:100100.
    PubMed     Abstract available


  6. RINK JS, Lin A, McMahon KM, Calvert AE, et al
    Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis.
    J Biol Chem. 2020 Nov 18. pii: RA120.014888. doi: 10.1074/jbc.RA120.014888.
    PubMed     Abstract available


    April 2020
  7. O'CONNOR KM, Das AB, Winterbourn CC, Hampton MB, et al
    Inhibition of DNA methylation in proliferating human lymphoma cells by immune cell oxidants.
    J Biol Chem. 2020 Apr 20. pii: RA120.013092. doi: 10.1074/jbc.RA120.013092.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: